Lupin gains on receiving USFDA approval for generic Roxicodone Tablets

15 Jun 2017 Evaluate

Lupin is currently trading at Rs. 1183.90, up by 3.20 points or 0.27% from its previous closing of Rs. 1180.70 on the BSE.

The scrip opened at Rs. 1180.70 and has touched a high and low of Rs. 1186.00 and Rs. 1173.50 respectively. So far 66508 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1750.00 on 29-Jul-2016 and a 52 week low of Rs. 1080.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 1192.00 and Rs. 1152.90 respectively. The current market cap of the company is Rs. 53354.94 crore.

The promoters holding in the company stood at 46.69%, while Institutions and Non-Institutions held 41.24% and 12.06% respectively.

Lupin has received final approval for its Oxycodone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Mallinckrodt's Roxicodone Tablets. The company’s Oxycodone Hydrochloride Tablets is the AR rated generic equivalent of Mallinckrodt's Roxicodone Tablets. Oxycodone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. As per IMS MAT March 2017, Roxicodone Tablets had US sales of $344 million.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2119.50 -31.55 (-1.47%)
01-Feb-2026 13:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.65
Dr. Reddys Lab 1225.20
Cipla 1318.20
Zydus Lifesciences 887.15
Lupin 2119.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×